Follow-up after cystectomy: regularly scheduled, risk adjusted, or symptom guided? Patterns of recurrence, relapse presentation, and survival after cystectomy by Nieuwenhuijzen, J A, de Vries, R R, van Tinteren, H, Bex, A, Van der Poel, H G, Meinhardt, W, Horenblas, S

Get full text

519 Combined radiofrequency ablation (RFA) and ipilimumab (IPI) in uveal melanoma: Phase 1b results from the SECIRA-UM trial by Blank, C, Foppen, M. Geukes, Prevoo, W, Meier, M, Van Thienen, H, Kvistborg, P, Van Tinteren, H, Schumacher, T, Haanen, J

Get full text

Adjuvant 5FU plus levamisole in colonic or rectal cancer: improved survival in stage II and III by Taal, B G, Van Tinteren, H, Zoetmulder, F A N

Get full text

A prospective pilot study to assess neoadjuvant chemotherapy for unresectable peritoneal carcinomatosis from colorectal cancer by Hompes, D., Aalbers, A., Boot, H., van Velthuysen, M.-L., Vogel, W., Prevoo, W., van Tinteren, H., Verwaal, V.

Get full text

Response to letter commenting on “Outcome of localised blastemal-type Wilms tumour patients treated according to intensified treatment in the SIOP WT 2001 protocol, a report of the... by van den Heuvel-Eibrink, M.M, Pritchard-Jones, K, van Tinteren, H, Graf, N

Get full text

Surgicopathological quality control in the CRITICS gastric cancer trial by Claassen, Y.H.M, De Steur, W.O, Hartgrink, H.H, Van Sandick, J.W, Dikken, J.L, Meershoek-Klein Kranenberg, E, Braak, J, Jansen, E.P.M, Van Grieken, N.C.T, Putter, H, Trip, A, Boot, H, Cats, A, Sikorska, K, Van Tinteren, H, Verheij, M, Van de Velde, C.J.H

Get full text

Upper Urinary Tract Cancer: Location is Correlated with Prognosis by van der Poel, H.G., Antonini, N., van Tinteren, H., Horenblas, S.

Get full text

2119 Capecitabine and bevacizumab (CB) maintenance treatment in metastatic colorectal cancer (mCRC): A cost-effectiveness analysis by Franken, M, Van Rooijen, E, Van Tinteren, H, May, A, Mol, L, Tije, A. Ten, Creemers, G.J, Velden, A. Van der, Van derTorren, A, Groot, C. Uyl-de, Punt, C, Koopman, M, Van Oijen, M

Get full text

Nephroblastoma: does the decrease in tumor volume under preoperative chemotherapy predict the lymph nodes status at surgery? by Godzinski, Jan, van Tinteren, Harm, de Kraker, Jan, Graf, Norbert, Bergeron, Christophe, Heij, Hugo, von Schweinitz, Dietrich, Fuchs, Joerg, Cecchetto, Giovanni, Audry, George, Gauthier, Frederic, Sandstedt, Bengt

Get full text

Optimized outcome prediction in breast cancer by combining the 70-gene signature with clinical risk prediction algorithms by Drukker, C. A., Nijenhuis, M. V., Bueno-de-Mesquita, J. M., Retèl, V. P., van Harten, W. H., van Tinteren, H., Wesseling, J., Schmidt, M. K., van’t Veer, L. J., Sonke, G. S., Rutgers, E. J. T., van de Vijver, M. J., Linn, S. C.

Get full text

OC-0534: An RCT on the value of postoperative accelerated radiotherapy in squamous cell head and neck cancer: final results by Langendijk, J.A, Kaanders, J.H, Doornaert, P, Van den Ende, P.L.A, Oei, S.B, Nuyts, S, Leemans, C.R, Van Tinteren, H

Get full text

Stromal and epithelial predominant Wilms tumours have an excellent outcome: The SIOP 93 01 experience by Verschuur, Arnauld C., Vujanic, Gordan M., Van Tinteren, Harm, Jones, Kathy Pritchard, de Kraker, Jan, Sandstedt, Bengt

Get full text

Treatment of relapsed Wilms tumour (WT) patients: Experience with topotecan. A report from the SIOP Renal Tumour Study Group (RTSG) by Mavinkurve-Groothuis, A. M. C., van den Heuvel-Eibrink, M. M., Tytgat, G. A., van Tinteren, H., Vujanic, G., Pritchard-Jones, K. L. P., Howell, L., Graf, N., Bergeron, C., Acha, T., Catania, S., Spreafico, F.

Get full text

Do we need randomised trials to evaluate diagnostic procedures? For by Van Tinteren, H, Hoekstra, O S, Boers, M

Get full text

OC-008: POPART vs CPORT in squamous cell head and neck cancer: Results of a multicenter randomised study of the Dutch head and neck Study Group by Langendijk, H, Kaanders, J.H, Doornaert, P, Burlage, F.R, Van den Ende, P.L.A, Oei, S.B, Keus, R.B, Nuyts, S, Leemans, C.R, Van Tinteren, H, Terhaard, C.H

Get full text

78. Surgicopathological quality control in the CRITICS gastric cancer trial by Claassen, Y.H.M, De Steur, W.O, Dikken, J.L, Hartgrink, H.H, Jansen, E.P.M, Trip, A.K, Van Grieken, N.C.T, Putter, H, Meershoek – Klein Kranenberg, E, Van Sandick, J.W, Boot, H, Cats, A, Aaronson, N.K, Sikorska, K, Van Tinteren, H, Verheij, M, Van de Velde, C.J.H

Get full text

Fluconazole versus itraconazole for the prevention of fungal infections in haemato-oncology by Huijgens, P C, Simoons-Smit, A M, van Loenen, A C, Prooy, E, van Tinteren, H, Ossenkoppele, G J, Jonkhoff, A R

Get full text

Expression of X-linked Inhibitor of Apoptosis as a Novel Prognostic Marker in Radically Resected Non-Small Cell Lung Cancer Patients by FERREIRA, Carlos G, VAN DER VALK, Paul, SPAN, Simone W, LUDWIG, Inge, SMIT, Egbert F, KRUYT, Frank A. E, PINEDO, Herbert M, VAN TINTEREN, Harm, GIACCONE, Giuseppe

Get full text

Survival after cystectomy for invasive bladder cancer by de Vries, R.R, Nieuwenhuijzen, J.A, Vincent, A, van Tinteren, H, Horenblas, S

Get full text

166: REST – a Dutch/UK randomized phase III trial on the use of thoracic radiotherapy in extensive stage small-cell lung cancer by Faivre-Finn, C, Hatton, M.Q, Snee, M, Jain, P, Wilson, P, McMenemin, R, Peedell, C, Bates, A, Garcia, A, Ironside, J, Falk, S, Van Tinteren, H, Keijser, A, Slotman, B.J

Get full text